IQVIA Holdings Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 IQVIA Holdings Inc 公司

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc簡介



公司代碼IQV

公司名稱IQVIA Holdings Inc

上市日期May 09, 2013

CEOBousbib (Ari)

員工數量88000

證券類型Ordinary Share

年結日May 09

公司地址2400 Ellis Road

城市DURHAM

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編27703

電話19199982000

網址https://ir.iqvia.com/

公司代碼IQV

上市日期May 09, 2013

CEOBousbib (Ari)

IQVIA Holdings Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

Ms. Carol J. Burt

Independent Director

7.01K

+1047.00%

Mr. James A. Fasano

Independent Director

2.74K

+1676.00%

Mr. John P. Connaughton

Independent Director

1.05K

+1047.00%

Mr. Bhavik Patel

President, Commercial Solutions

863.00

-84.00%

名稱

名稱/職務

職務

持股

持股變動

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.35M

--

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

46.46K

-907.00%

Mr. John G. Danhakl

Independent Director

30.85K

-117138.00%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

21.11K

--

Ms. Colleen A. Goggins

Independent Director

16.83K

+1592.00%

Dr. John M. Leonard, M.D.

Lead Independent Director

15.38K

+1592.00%

收入明細

單位: USD更新時間: 1月6日週二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

Americas

1.93B

47.15%

Europe & Africa Region

1.30B

31.63%

Asia Pacific Region

870.00M

21.22%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 1月10日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

其他

67.87%

持股股東

佔比

The Vanguard Group, Inc.

11.54%

Harris Associates L.P.

6.71%

BlackRock Institutional Trust Company, N.A.

5.57%

State Street Investment Management (US)

4.45%

GIC Private Limited

3.86%

其他

67.87%

股東類型

持股股東

佔比

Investment Advisor

47.72%

Investment Advisor/Hedge Fund

36.38%

Sovereign Wealth Fund

4.96%

Pension Fund

4.15%

Hedge Fund

3.24%

Research Firm

2.38%

Bank and Trust

2.02%

Individual Investor

0.92%

Family Office

0.15%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

2132

171.19M

100.94%

-15.17M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

2023Q3

1925

170.01M

92.82%

-4.41M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

19.41M

11.4%

-186.59K

-0.95%

Sep 30, 2025

Harris Associates L.P.

11.39M

6.69%

-365.92K

-3.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.44M

5.54%

+67.42K

+0.72%

Sep 30, 2025

State Street Investment Management (US)

7.55M

4.43%

-75.92K

-1.00%

Sep 30, 2025

GIC Private Limited

6.54M

3.84%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.35M

2.55%

+132.36K

+3.14%

Sep 30, 2025

CPP Investments

4.12M

2.42%

-52.91K

-1.27%

Sep 30, 2025

AllianceBernstein L.P.

3.60M

2.11%

+41.64K

+1.17%

Sep 30, 2025

Boston Partners

3.56M

2.09%

+1.58M

+80.09%

Sep 30, 2025

Artisan Partners Limited Partnership

3.43M

2.02%

+161.09K

+4.92%

Sep 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比9.1%

Langar Global HealthTech ETF

佔比7.83%

Global X HealthTech ETF

佔比5.5%

VanEck Biotech ETF

佔比4.98%

iShares Biotechnology ETF

佔比3.23%

iShares Health Innovation Active ETF

佔比3.05%

Adaptive Core ETF

佔比3.04%

Invesco Bloomberg Pricing Power ETF

佔比2.24%

Running Oak Efficient Growth ETF

佔比2.16%

Invesco Zacks Mid-Cap ETF

佔比2.08%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據